REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Hengrui Poland Therapeutics Sp. z o.o. (Poland)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Secondary Activities: Pharmaceutical Preparation Manufacturing | Medical Equipment and Supplies Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Hengrui Poland Therapeutics Sp. z o.o. Profile Updated: July 23, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Hengrui Poland Therapeutics Sp. z o.o. is based in Poland, with the head office in Warsaw. The company operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) sector. It was established on February 22, 2019. Its’ total assets recorded a growth of 617.39%.

Headquarters
Ul. Rondo Ignacego Daszynskiego 2B
Warsaw; Mazowieckie; Postal Code: 00-843

Contact Details: Purchase the Hengrui Poland Therapeutics Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Hengrui Poland Therapeutics Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Hengrui Poland Therapeutics Sp. z o.o. report to view the information.
Incorporation Date:
February 22, 2019
Key Executives
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Proxy
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Hengrui Poland Therapeutics Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Total operating revenue
1612249.33%▲
Operating profit (EBIT)
39.34%▲
Net Profit (Loss) for the Period
39.34%▲
Total assets
617.39%▲
Total equity
96.87%▲
Return on Equity (ROE)
1484.76%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo